Research graph
References from Clinical evidence mapping for 54 types of oral Chinese patent medicines used in adult bronchial asthma: predominantly as add-on therapy and partially as monotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study
10.1136/bmj.321.7256.255 · 2000 · External reference
Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: a systematic review
10.1016/j.rmed.2025.108202 · 2025 · External reference
Agree II: advancing guideline development, reporting and evaluation in health care
10.1503/cmaj.090449 · 2010 · External reference
Global asthma report 2022: a wake-up call to enhance care and treatment for asthma globally
10.5588/ijtld.22.0483 · 2022 · External reference
The extract of Cordyceps sinensis inhibited airway inflammation by blocking NF-κB activity
10.1007/s10753-011-9402-9 · 2012 · External reference
Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions
2019 · External reference
Does inhaler adherence really matter in severe asthma?
2024 · External reference
Clinical trial registration: a statement from the international committee of medical journal editors
10.1016/s0140-6736(04)17034-7 · 2004 · External reference
A randomized controlled trial study protocol of modified mahuang-fuzi-xixin decoction in the treatment of patients with mild bronchial asthma during acute exacerbation
10.1097/md.0000000000021858 · 2020 · External reference
Antiviral and immune enhancement effect of Platycodon grandiflorus in viral diseases: a potential broad-spectrum antiviral drug
10.3390/molecules30040831 · 2025 · External reference
Factors influencing the quality of clinical trials on traditional Chinese medicine-qualitative interviews with trial auditors, Clinicians and academic researchers
10.1016/j.ctcp.2019.09.004 · 2019 · External reference
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
10.1016/s0140-6736(19)31147-x · 2019 · External reference
Efficacy of Jia Wei Yang He formula as an adjunctive therapy for asthma: study protocol for a randomized, double blinded, controlled trial
10.1186/s13063-018-2739-8 · 2018 · External reference
Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants
10.1016/j.anorl.2014.11.001 · 2015 · External reference
Traditional Chinese medicine use may reduce medical utility in patients with asthma: a nationwide population-based retrospective cohort study
10.1093/qjmed/hcaa252 · 2022 · External reference
Newcastle-Ottawa scale: comparing reviewers' to authors' assessments
10.1186/1471-2288-14-45 · 2014 · External reference
European respiratory society guidelines for the diagnosis of asthma in adults
10.1183/13993003.01585-2021 · 2022 · External reference
The reporting quality and risk of bias of randomized controlled trials of acupuncture for migraine: methodological study based on STRICTA and RoB 2.0
10.1016/j.ctim.2020.102433 · 2020 · External reference
In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4
10.3390/ijerph13010084 · 2016 · External reference
Managing adult asthma: the 2019 GINA guidelines
10.3949/ccjm.87a.19136 · 2020 · External reference
What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products
10.1186/s13643-016-0204-x · 2016 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1016/j.ijsu.2021.105906 · 2021 · External reference
Unlocking better asthma control: a narrative review of adherence to asthma therapy and innovative monitoring solutions
10.3390/jcm13226699 · 2024 · External reference
GRADE guidelines:18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
10.1016/j.jclinepi.2018.01.012 · 2019 · External reference
Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 · External reference
Perspectives,experiences, and practices of healthcare professionals and patients towards herbdrug interaction: a systematic review of qualitative studies
10.1002/ptr.8384 · 2025 · External reference
Cordyceps militaris polysaccharide alleviates ovalbumin-induced allergic asthma through the Nrf2/HO-1 and NF-κB signaling pathways and regulates the gut microbiota
10.1016/j.ijbiomac.2023.124333 · 2023 · External reference
Armeniacae semen amarum: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics
2024 · External reference
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007 · External reference
Guideline on treating community-acquired pneumonia with Chinese patent medicines
10.1016/j.phrs.2023.106919 · 2023 · External reference
Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions
10.1016/j.jep.2013.09.055 · 2013 · External reference
Traditional Chinese medicine ZHENG identification of bronchial asthma: clinical investigation of 2500 adult cases
10.1016/j.ctim.2016.12.003 · 2017 · External reference
Anti-inflammatory mechanisms and translational relevance of Cordyceps sinensis and its bioactive constituents
10.2147/jir.s582921 · 2026 · External reference
Perspectives,experiences, and practices of healthcare professionals and patients towards herbdrug interaction: a systematic review of qualitative studies
10.1002/ptr.8384 · ExternalCitation · doi-reference
The extract of Cordyceps sinensis inhibited airway inflammation by blocking NF-κB activity
10.1007/s10753-011-9402-9 · ExternalCitation · doi-reference
Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants
10.1016/j.anorl.2014.11.001 · ExternalCitation · doi-reference
Factors influencing the quality of clinical trials on traditional Chinese medicine-qualitative interviews with trial auditors, Clinicians and academic researchers
10.1016/j.ctcp.2019.09.004 · ExternalCitation · doi-reference
Traditional Chinese medicine ZHENG identification of bronchial asthma: clinical investigation of 2500 adult cases
10.1016/j.ctim.2016.12.003 · ExternalCitation · doi-reference
The reporting quality and risk of bias of randomized controlled trials of acupuncture for migraine: methodological study based on STRICTA and RoB 2.0
10.1016/j.ctim.2020.102433 · ExternalCitation · doi-reference
Cordyceps militaris polysaccharide alleviates ovalbumin-induced allergic asthma through the Nrf2/HO-1 and NF-κB signaling pathways and regulates the gut microbiota
10.1016/j.ijbiomac.2023.124333 · ExternalCitation · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1016/j.ijsu.2021.105906 · ExternalCitation · doi-reference
GRADE guidelines:18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
10.1016/j.jclinepi.2018.01.012 · ExternalCitation · doi-reference
Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions
10.1016/j.jep.2013.09.055 · ExternalCitation · doi-reference
Guideline on treating community-acquired pneumonia with Chinese patent medicines
10.1016/j.phrs.2023.106919 · ExternalCitation · doi-reference
Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: a systematic review
10.1016/j.rmed.2025.108202 · ExternalCitation · doi-reference
Clinical trial registration: a statement from the international committee of medical journal editors
10.1016/s0140-6736(04)17034-7 · ExternalCitation · doi-reference
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · ExternalCitation · doi-reference
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
10.1016/s0140-6736(19)31147-x · ExternalCitation · doi-reference
Traditional Chinese medicine use may reduce medical utility in patients with asthma: a nationwide population-based retrospective cohort study
10.1093/qjmed/hcaa252 · ExternalCitation · doi-reference
A randomized controlled trial study protocol of modified mahuang-fuzi-xixin decoction in the treatment of patients with mild bronchial asthma during acute exacerbation
10.1097/md.0000000000021858 · ExternalCitation · doi-reference
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study
10.1136/bmj.321.7256.255 · ExternalCitation · doi-reference
European respiratory society guidelines for the diagnosis of asthma in adults
10.1183/13993003.01585-2021 · ExternalCitation · doi-reference
Newcastle-Ottawa scale: comparing reviewers' to authors' assessments
10.1186/1471-2288-14-45 · ExternalCitation · doi-reference
Efficacy of Jia Wei Yang He formula as an adjunctive therapy for asthma: study protocol for a randomized, double blinded, controlled trial
10.1186/s13063-018-2739-8 · ExternalCitation · doi-reference
What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products
10.1186/s13643-016-0204-x · ExternalCitation · doi-reference
Agree II: advancing guideline development, reporting and evaluation in health care
10.1503/cmaj.090449 · ExternalCitation · doi-reference
Anti-inflammatory mechanisms and translational relevance of Cordyceps sinensis and its bioactive constituents
10.2147/jir.s582921 · ExternalCitation · doi-reference
In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4
10.3390/ijerph13010084 · ExternalCitation · doi-reference
Unlocking better asthma control: a narrative review of adherence to asthma therapy and innovative monitoring solutions
10.3390/jcm13226699 · ExternalCitation · doi-reference
Antiviral and immune enhancement effect of Platycodon grandiflorus in viral diseases: a potential broad-spectrum antiviral drug
10.3390/molecules30040831 · ExternalCitation · doi-reference
Managing adult asthma: the 2019 GINA guidelines
10.3949/ccjm.87a.19136 · ExternalCitation · doi-reference
Global asthma report 2022: a wake-up call to enhance care and treatment for asthma globally
10.5588/ijtld.22.0483 · ExternalCitation · doi-reference
